State Street Corp Fennec Pharmaceuticals Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, State Street Corp holds 336,494 shares of FENC stock, worth $3.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

336,494

Previous 338,133 0.48%

Holding current value

$3.11 Million

Previous $2.06 Million 35.6%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$5.01 - $8.4 $8,211 - $13,767	-1,639 Reduced 0.48%	336,494 $2.79 Million
Q1 2025 May 15, 2025	SELL	$5.54 - $7.02 $8,753 - $11,091	-1,580 Reduced 0.47%	338,133 $2.06 Million
Q4 2024 Feb 14, 2025	BUY	$3.99 - $6.37 $45,701 - $72,961	11,454 Added 3.49%	339,713 $2.15 Million
Q3 2024 Nov 14, 2024	BUY	$4.85 - $6.73 $34,207 - $47,466	7,053 Added 2.2%	328,259 $1.64 Million
Q2 2024 Aug 14, 2024	BUY	$6.02 - $10.99 $106,475 - $194,380	17,687 Added 5.83%	321,206 $1.96 Million
Q1 2024 May 15, 2024	BUY	$8.82 - $11.12 $334,004 - $421,103	37,869 Added 14.26%	303,519 $3.38 Million
Q4 2023 Feb 14, 2024	BUY	$6.48 - $11.61 $27,319 - $48,947	4,216 Added 1.61%	265,650 $2.98 Million
Q3 2023 Nov 14, 2023	SELL	$7.15 - $8.94 $364 - $455	-51 Reduced 0.02%	261,434 $1.96 Million
Q2 2023 Aug 14, 2023	BUY	$7.27 - $9.82 $1.9 Million - $2.57 Million	261,485 New	261,485 $2.31 Million
Q2 2021 Aug 16, 2021	SELL	$5.96 - $7.85 $1.95 Million - $2.57 Million	-327,151 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.21 - $8.68 $86,319 - $120,652	-13,900 Reduced 4.08%	327,151 $2.03 Million
Q4 2020 Feb 16, 2021	BUY	$5.99 - $8.55 $76,342 - $108,969	12,745 Added 3.88%	341,051 $2.54 Million
Q3 2020 Nov 10, 2020	BUY	$5.19 - $10.17 $241,013 - $472,274	46,438 Added 16.48%	328,306 $1.99 Million
Q2 2020 Aug 14, 2020	BUY	$5.43 - $9.39 $1.53 Million - $2.65 Million	281,868 New	281,868 $2.35 Million

Others Institutions Holding FENC

# of Institutions

Shares Held

14M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $241M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Fennec Pharmaceuticals Inc. Transaction History